Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure

Kidney International

Volumn 56, Issue 2, 1999, Pages 383-392

  Rostand, Stephen G ^a,b,c   Drüeke, Tilman B ^a,b  

^a Cardio Renal Physiology and Medicine Division of Nephrology Department of Medicine   (United States)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c University of Alabama at Birmingham   (United States)

Author keywords

Blood pressure; Endstage renal disease; Fibrosis; Hyperparathyroidism; Hypertension; Myocardial ischemia; PTH; Uremia

Indexed keywords

CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; PARATHYROID HORMONE; VITAMIN D;

ATHEROSCLEROSIS; CALCIFICATION; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; DISEASE ASSOCIATION; DYSLIPIDEMIA; GLUCOSE INTOLERANCE; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; HYPERPARATHYROIDISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; REVIEW; UREMIA;

EID: 0032806647     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00575.x     Document Type: Article

References (124)

1. 1. PARFREY PS, HARNETT JD, BARRE PE: The natural history of myocardial disease in dialysis patients. J Am Soc Nephrol 2:2-12, 1991
2. 2. LONDON GM, DRÜEKE TB: Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int 51:1678-1695, 1997
3. 3. MORGAN JP: Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. N Engl J Med 325:625-632, 1991
4. 4. WANG R, WU L, KARPINSKI E, PANG PK: The changes in contractile status of single vascular smooth muscle cells and ventricular cells induced by bPTH-(1-34). Life Sci 52:793-801, 1993
5. 5. SMOGORZEWSKI M: PTH, chronic renal failure and myocardium. Miner Electrolyte Metab 21:55-62, 1995
6. 6. ONGINO K, BURKHOFF D, BILEZIKIAN JP: The hemodynamic basis for the effects of parathyroid hormone (PTH) and PTH-related protein. Endocrinology 136:3024-3030, 1995
7. 7. MASSRY SG: Parathyroid hormone and uremic myocardiopathy. Contrib Nephrol 4 1:231-239, 1984
8. 8. MASSRY SG, SMOGORZEWSKI M: The mechanisms responsible for the PTH-induced rise in cytosolic calcium in various cells are not uniform. Miner Electrolyte Metab 21:13-28, 1995
9. 9. BACZYNSKI R, MASSRY SG, KOHAN R, MAGOTT M, SAGLIKES Y, BRAUTBAR N: Effect of parathyroid hormone on myocardial energy metabolism in the rat. Kidney Int 27:718-725, 1985
10. 10. BOGIN E, LEVI J, HARARY I, MASSRY SG: Effects of parathyroid hormone on oxidative phosphorylation of heart mitochondria. Miner Electrolyte Metab 7:151-156, 1982
11. 11. SMOGORZEWSKI M, PERNA AF, BORUM PR, MASSRY SG: Fatty acid oxidation in the myocardium: Effects of parathyroid hormone and CRF. Kidney Int 34:797-803, 1988
12. 12. PERNA AF, SMOGORZEWSKI M, MASSRY SG: Verapamil reverses PTH-or CRF-induccd abnormal fatty acid oxidation in muscle. Kidney Int 34:774-778, 1988
13. 13. ZAHAVI I, CHAGNAC A, DJALDETTI M, LEVI J: Effect of verapamil on uremic myocardial disease in the rat. J Submicrosc Cytol 17:637-644, 1985
14. 14. QING DP, DING H, VADGAMA J, WU YY, KOPPLE JD: Elevated myocardial cytosolic calcium impairs insulin-like growth factor-1-stimulated protein synthesis in chronic renal failure. J Am Soc Nephrol 10:84-92, 1999
15. 15. RAINE AEG, BEDFORD L, SIMPSON AWM, ASHLEY CC, BROWN R, WOODHEAD JS, LEDINGHAM JGG: Hyperparathyroidism. platelet intracellular free calcium and hypertension in chronic renal failure. Kidney Int 43:700-705, 1993
16. 16. DRUML W, KELLY RA, ENGLAND BK, O'HARA DS, MITCH WE: Effects of acute and chronic uremia on active cation transport in rat myocardium. Kidney Int 38:1061-1067, 1990
17. 17. UREÑA P, KUBRUSLY M, MANNSTADT M, HRUBY M, TRINII TRANG TAN M-M, SILVE C, LACOUR B, ABOUR-SAMRA A-B, SEGRE GV, DRÜEKE T: The renal PTH/PTHrP receptor is down-regulated in rats with chronic failure. Kidney Int 45:605-611, 1994
18. i. Kidney Int 47:1182-1186, 1995
19. 19. NISHIZAWA Y, KOVAMA H, SHIOI A, JONO S, HINO M, MORII H: Parathyroid hormone-related peptide and models of vascular disease: Its expression and action in vascular smooth muscle cells. Miner Electrolyte Metab 21:152-156, 1995
20. 20. ROSTAND SG, SANDERS C, KIRK KA, RUTSKY EA, FRASER RG: Myocardial calcification and cardiac dysfunction in chronic renal failure. Am J Med 85:651-656, 1988
21. 21. ROSTAND SG, SANDERS PC, RUTSKY EA: Cardiac calcification in uremia. Contrib Nephrol 106:26-29, 1993
22. 22. CORATELLI P, BUONGIORNO E, PEIRARULO F, CORCIULO R, GIANNATTASIO M, PASSAVANTI G, ANTONELLI G: Pathogenetic aspects of uremic cardiomyopathy. Miner Electrolyte Metab 15:1-8, 1989
23. 23. OHARA N, HIRAMATSU K, SHIGEMATSU S, HAYASHI Y, ISHIHARA F, AIZAWA T, NIWA A, YAMADA T, HASHIZUME K: Effect of parathyroid hormone on left ventricular diastolic function in patients with primary hyperparathyroidism. Miner Electrolyte Metab 21:63-66, 1995
24. 24. SHANE E, MANCINI D, AARONSON K, SILVERBERG SJ, SIEBEL MJ, ADESSO V, MCMAHON DJ: Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med 103:197-207, 1997
25. 25. DRÜEKE T, FLEURY I, TUURE Y, DE VERNEJOUL P, FAUCHET M, LESOURD P, PAILLEUR C, CROSNIER J: Effect of parathyroidectomy on left ventricular function in hemodialysis patients. Lancet 1:112-114, 1980
26. 26. GAFTER U, BATILER A, ELDAR M, ZEVIN D, NEUFELD HN, LEVI J: Effect of hyperparathyroidism on cardiac function in patients with end-stage renal disease. Nephron 41:30-33, 1985
27. 27. FELLNER SK, LANG RM, NEUMANN A, BUSHINSKY DA, BOROW KM: Parathyroid hormone and myocardial performance in dialysis patients. Am J Kidney Dis 18:320-325, 1991
28. 3. Contrib Nephrol 41:433-437, 1984
29. 3, and cardiovascular function in rais. J Clin Invest 79:1706-1712, 1987
30. 3 with cardiovascular function. II. Direct and indirect effects. Am J Physiol 253:E675-E683, 1987
31. 31. HARNETT JD, PAREREY PS, GRIFFITHS SM, GAULT MH, BARRE P, GUTTMANN RD: Left ventricular hypertrophy in end-stage renal disease. Nephron 48:107-115, 1988
32. 32. ROSTAND SG, RUTSKY EA: Ischemic heart disease in chronic renal failure: Demography, epidemiology, and pathogenesis, in Cardiac Dysfunction in Chronic Uremia, edited by Parfrey PS, Harnett JD, Norwell, Kluwer Academic Publishers, 1992, p 53
33. 33. MALL G, RAMBAUSEK M, NEUMEISIER A, KOLLMAR S, VETIERLEIN F, RITZ E: Myocardial interstitial fibrosis in experimental uremia-implications for cardiac compliance. Kidney Int 33:804-811, 1988
34. 34. LONDON GM, MARCHAIS SJ, SAFAR ME, GENEST AF, GUERIN AP, METVIER F, CHEDID K, LONDON AM: Aortic and large artery compliance in end-stage renal failure. Kidney Int 31:137-142, 1990
35. 35. GERDES AM, CAMPBELL SC, HILBELINK DR: Structural remodelling of cardiac myocytes in rats with arteriovenous fistulas. Lab Invest 59:857-861, 1988
36. 36. DUPREZ D, BAUWENS F, DE BUYZERE M, DE BACKER T, KAUFMAN J-M, VAN HOECKE J, VERMUELEN A, CLEMENT DL: Relationship between parathyroid hormone and left ventricular mass in moderate essential hypertension. J Hypertens 9(Suppl 6):S116-S117, 1991
37. 37. LONDON GM, DE VERNEJOUL M-C, FABIANI F, MARCHAIS SJ, GUERIN AP, METVIER F, LONDON AM, LLACH F: Secondary hyperthyroidism and cardiac hypertrophy in hemodialysis patients. Kidney Int 32:900-907, 1987
38. 38. SYMONS G, FURTUNE F, GREENBAUM RA, DANDONA P: Cardiac hypertrophy, hypertrophic cardiomyopathy, and hyperparathyroidism-An association. Br Heart J 54:539-542, 1985
39. 39. SCHLÜTER K-D, PIPER HM: Trophic effects of catecholamines and parathyroid hormone on adult ventricular cardiomyocytes. Am J Physiol 263:H1739-H1746, 1992
40. 40. AMANN K, RITZ E, WIEST G, KLAUS G, MALL G: A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol 4:1814-1819, 1994
41. 41. SATO S, OHTA M, KAWAGUCHI Y, OKADA H, ONO M, SAITO H, UTSUNOMIYA M, TAMURA T, SUGIMOTO K, TAKAMIZAWA S, TANAKA H, SIGEMATSU T, TOJO K, SAKAI O: Effects of parathyroidectomy on left ventricular mass in patients with hyperparathyroidism. Miner Electrolyte Metab 21:67-71, 1995
42. 42. DOMINICZAK AF, LYALL F, MORTON JJ, DARGIE HJ, BOYLE IT, TUNF TT, MURRAY G, SEMPLE PF: Blood pressure, left ventricular mass and intracellular calcium in primary hyperparathyroidism. Clin Sci 78: 127-132, 1990
43. 43. STEFENELLI T, MAYR M, BERGLER-KLEIN J, GLOBITS SA, WOLOSZCZUK W, NIERDERLE B: Primary hyperparathyroidism: Incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med 95:197-202, 1993
44. 44. RAMBAUSEK M, RITZ E, MALL G, MEHLS O, KATUS H: Myocardial hypertrophy in rats with renal insufficiency. Kidney Int 28:773-782, 1985
45. 3 induced down-regulation of the vitamin D receptor in growth plate chondrocytes in vitro. Kidney Int 51:45-51, 1997
46. 3 upregulates the phosphatidyl-inositol signalling pathway in human keratinocytes by increasing phosolipase C level. J Clin Invest 96:602-607, 1995
47. 3 and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J Clin Invem 97:1577-1588, 1996
48. 48. CHEN S, WU J, HSIEH J-C, WHITFIELD JK, JURUTKA PW, HAUSSLER MR, GARDNER DG: Suppression of ANP gene transcription by liganded vitamin d receptor: Involvement of specific receptor domains. Hypertension 31:1338-1342, 1998
49. 49. PARK CW, ON YS, SHIN YS, KIM C-M, KIM Y-S, KIM S-Y, CHOI EJ, CHANG YS, BANG BK: Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 33:73-81, 1999
50. 50. WEISHAAR RE, KIM S-M, SAUNDERS DE, SIMPSON RU: Involvement of vitamin D with cardiovascular function III: Effects on physical and morphological properties. Am J Physiol 258:E134-E142, 1990
51. 51. LACOUR B, BASILE C, DRÜEKE T, FUNCK-BRENTANO J-L: Parathyroid function and lipid metabolism in the rat. Miner Electrolyte Metab 7:157-165, 1982
52. 52. LACOUR B, ROULLETT J-B, LIAGRE A-M, JORGETTI V, BEYNE P, DUBOSE C, DRÜEKE T: Serum lipoprotein disturbances in primary and secondary hyperthyroidism and effects of parathyroidectomy. Am J Kidney Dis 8:422-429, 1986
53. 53. AKMAL M, KASIM SE, SOLIMAN SE, MASSRY SG: Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure. Kidney Int 37:854-858, 1990
54. 54. KLIN M, SMOGORZEWSKI M, NI Z, ZHANG G, MASSRY SG: Abnormalities in hepatic lipase in chronic renal failure: Role of excess parathyroid hormone. J Clin Invest 97:2167-2173, 1996
55. 55. LIANG K, OVEISI F, VAZIRI ND: Role of secondary hyperparathyroidism in the genesis of hypertriglyceridemia und VLDL receptor deficiency in chronic renal failure. Kidney Int 53:626-630, 1998
56. 3, apolipoprotein A-I, and high density lipoprotein cholesterol. Arterioscler Thromb 12:671-674, 1992
57. 57. LIND L, HANNI A, LITHELL H, HVARFNER A, SORENSEN OH, LJUNGHALL S: Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens 8:894-901, 1995
58. 3 and rat vascular smooth muscle growth. Hypertension 13:954-959, 1989
59. 59. WAREHAM NJ, BYRNE CD, CARR C, DAY NE, BOUCHER BJ, HALES CN: Glucose intolerance is associated with altered calcium homeostasis: A possible link between increased serum calcium concentration and cardiovascular disease. Metabolism 46:1171-1177, 1997
60. 60. AKMAI M, MASSRY SG, GOLDSTEIN DA, FANTI P, WEISZ A, DEFRONZO RA: Role of parathyroid hormone in the glucose intolerance of chronic renal failure. J Clin Invest 75:1037-1044, 1985
61. 61. PERNA AF, FADDA GZ, ZHOU X-J, MASSRY SG. Mechanisms of impaired insulin secretion after chronic excess of parathyroid hormone. Am J Physiol 259:F210-F216, 1990
62. 62. FADDA GZ, HAJJAR SM, PERNA AF, ZHOU X-J, LIPSON LG, MASSRY SG: On the mechanism of impaired insulin secretion in chronic renal failure. J Clin Invest 87:255-261, 1991
63. 63. AMEND WJC JR, STEINBERG SV, LOWRIE EG, LAZARUS JM, SOELDNER JS, HAMPFRS CL, MERRILL JP:The influence of serum calcium and parathyroid hormone upon glucose metabolism in uremia. J Lab Clin Med 86:435-444, 1975
64. 64. KIM H, KALKHOFF RK, COSTRINI NV, CERLETTY JM, JACOBSON M: Plasma insulin disturbance in primary hyperthyroidism. J Clin Invest 50:2596-2605, 1971
65. 65. LINDALL A, CARMENA R, COHEN S, COMTY C: Insulin hypersecretion in patients on chronic hemodialysis: Role of the parathyroids. J Clin Endocrinol 32:653-658, 1971
66. 66. DEFRONZO RA, ALVESTRAND A, SMITH D, HENDLER R, HENDLER E, WAHREN J: Insulin resistance in uremia. J Clin Invest 67:563-568, 1981
67. 3 corrects insulin and lipid abnormalities in uremia. Kidney Int 53:1353-1357, 1998
68. 68. MOORE RD: Elevation of intracellular pH by insulin in frog skeletal muscle. Biochem Biophys Res Commun 91:900-904, 1979
69. 69. MOORE RD, FIDELMAN ML, SEEHOLZER SH: Correlation between insulin action upon glycolysis and change in intracellular pH. Biochem Biophys Res Commun 91:905-910, 1979
70. 70. MOORE RD: Effect of insulin upon the sodium pump in frog skeletal muscle. J Physiol 232:23-45, 1973
71. 3: Interaction with parathyroid-hormone-dependent inhibition. Pflügers Arch 424:391-397, 1993
72. + exchange in opossum kidney cells. J Am Soc Nephrol 9:175-181, 1998
73. 73. AMANN K, WIEST G, ZIMMER G, GRETZ N, RITZ E, MALL G: Reduced capillary density in the myocardium of uremic rats: A stereological study. Kidney Int 42:1079-1085, 1992
74. 74. AMANN K, TÖRNIG J, FLETCHENMACHER CH, NABOKOV A, MALL G, RITZ E: Blood-pressure-independent wall thickening of intramyocardial arterioles in experimental uraemia: Evidence for a permissive action of PTH. Nephrol Dial Transplant 10:2043-2048, 1995
75. 75. SCHLEIFFER R, PERNOT F, JONES R: Endothelium is a target organ of parathyroid secretions in genetic hypertensive rats. Horm Metab Res 27:16-18, 1995
76. 76. PIROLA CJ, WANG H, KAMYAR A, WU S, ENOMOTO H, SHARIFI B, FORRESTER JS, CLEMENS TL, FAGIN JA: Angiotetisin II regulates parathyroid hormone-related protein expression in cultured aortic smooth muscle cells through transcriptional and post-transcriptional mechanisms. J Biol Chem 268:1987-1994, 1993
77. 77. NODA M, KATOH T, KUROKAWA K, TAKUWA Y: Increased expression of parathyroid hormone-related peplide gene in blood vessels of spontaneously hypertensive rats. Hypertension 30:1284-1288, 1997
78. 78. JIANG B, MORIMOTO S, YANG J, FUKUO K, HIROTAMI A, KITANO S, OGIHARA T: Parathyroid hormone-related protein upregulates interleukin-1β-induced nitric oxide synthesis. Hypertension 30:922-927, 1997
79. 79. MOHTAI M, YAMAMOTO T: Smooth muscle cell proliferation in the rat coronary artery induced by vitamin D. Arteriosclerosis 63:193-202, 1987
80. 3 modulates growth of vascular smooth muscle cells. J Clin Invest 87:1889-1895, 1991
81. 81. FLISER D, FRANEK E, FODE P, STEFANSKI A, SCHMITT CP, LYONS M, RITZ E: Subacute infusion of physiologic doses of parathyroid hormone raises blood pressure in humans. Nephrol Dial Transplant 12:933-938, 1997
82. 82. DRÜEKE TB, BOURGOUIN P, POINTILLART A, LACOUR B: Disturbances of calcium metabolism in experimental hypertension. Miner Electrolyte Metab 16:6-11, 1990
83. 83. MERKE J, LUCAS PA, SZABO A, COURNOT-WITMER G, MALL G, BOUILLON R, DRÜEKE T, MANN J, RITZ E: Hyperparathyroidism and abnormal calcitriol metabolism in the spontaneously hypertensive rat. Hypertension 13:233-242, 1989
84. 84. NAKAMURA M, SUZUKI H, YAMAKAWA H, OHNO Y, SARUTA T: Calcium restriction accelerates salt-induced hypertension in young spontaneously hypertensive rats. Am J Med Sci 307(Suppl I):S138-S141, 1994
85. 85. SCHLEIFFER R, XUE H, MCCARRON DA, BUKOSKI RD: Effect of chronic and subacute parathyroidectomy on blood pressure and resistance artery contractility in the spontaneously hypertensive rat. J Hypertens 11:709-716, 1993
86. 86. SCHLEIFFER R, GALLUSER M, KACHELHOFFER J, RAUL F: Dietary calcium supplementation, blood pressure, and intestinal calcium absorption. Am J Med Sci 307(Suppl 1):S116-S119, 1994
87. 87. MANN JFE, WIECEK A, BOMMER J, GANTEN U, RITZ E: Effects of parathyroidectomy on blood pressure in spontaneously hypertensive rats. Nephron 45:46-32, 1987
88. 2+ fixes. J Clin Invest 76:1147-1154, 1985
89. 89. RESNICK LM, NICHOLSON JP, LARAGH JH: Calcium metabolism in essential hypertension: Relationship to altered renin system activity. Fed Proc 45:2739-2745, 1986
90. 90. RESNICK LM, MULLER FB, LARAGH JH: Calcium-regulating hormones in essential hypertension: Relation to plasma renin activity and sodium metabolism. Ann Int Med 105:649-654, 1986
91. 91. YOUNG EW, MORRIS CD, HOLCOMB S, MCMILLAN G, MCCARRON DA: Regulation of parathyroid hormone and vitamin D in essential hypertension. Am J Hypertens 8:957-964, 1995
92. 92. BUCHER HC, COOK RJ, GUYATT GH, LANG JD, COOK DJ, HATALA R, HUNT DL: Effects of dietary calcium supplementation on blood pressure: A meta-analysis of randomized controlled trials. JAMA 275:1016-1022, 1996
93. 93. PIZZARELLI F, FABRIZI F, POSTORINO M, CURATOLA G, ZOCCALI C, MAGGIORE Q: Parathyroidectomy and blood pressure in hemodialysis patients. Nephron 63:384-389, 1993
94. 94. KRAUSE R, BENNHOLD I, BRITZKE K, KLAMROTH R, BÜHRING M, CHEN TC, HOLICK MF, SCHMIDT-GAYK H, ROTH H-J, BOLDT F, KIRCHNER M: Reduction of cardiac risk factors in coronary and hemodialysis patients after UV (B) therapy, in Biologic Effects of Light 1995: Proceedings of a Symposium, Atlanta, Georgia, USA, October 9-11, 1995, edited by HOLICK MF, JUNG EG, Berlin, Walter de Gruyter, 1996, p 70
95. 95. UCHIMOTO S, TSUMURA K, KISHIMOTO N, MORII H: Implication of parathyroid hormone for the development of hypertension in young spontaneously hypertensive rats. Miner Electrolyte Metab 21:82-86, 1995
96. 96. EJERBLAD S: Uraemic myocardial disease. Acta Chir Scand 145:345-353, 1979
97. 97. BARENBROCK M, SPIEKER C, LASKE V, HEIDENREICH S, HOHAGF H, BACHMANN J, HOEKS APG, RAHN K-H: Studies of the vessel wall properties in hemodialysis patients. Kidney Int 45:1397-1400, 1994
98. 98. AALKJAER C, PEDERSEN EB, DANIELSEN H, FJELDBERG O, JESPERSEN B, KJAER T, SORENSEN SS, MULVANY MJ: Morphological and functional characteristics of isolated resistance vessels in advanced uraemia. Clin Sci 71:657-663, 1986
99. + exchange in the pathophysiology of essential hypertension. Am J Hypertens 9:703-707, 1996
100. + exchanger in essential hypertension. Kidney Int 45:1037-1043, 1993
101. +) exchange inhibition increases blood pressure in spontaneously hypertensive rat. Am J Med Sci 308:145-151, 1994
102. 102. SHAN J, RESNICK LM, LEWANCZUK RZ, KARPINSKI E, LI B, PANG PKT: 1,25-Dihydroxyvitamin D as a cardiovascular hormone: effects on calcium current and cytosolic free calcium in vascular smooth muscle cells. Am J Hypertens 6:983-988, 1993
103. 2+ and force generation in resistance arteries. Am J Physiol 270:H230-H237, 1996
104. 3. Am J Hypertens 6:388-396, 1993
105. 3 on blood pressure and resistance artery contractility in the spontaneously hypertensive rat. Am J Hypertens 6:944-950, 1993
106. 3 enhances resistance artery contractile properties. Hypertension 16:523-531, 1990
107. 107. SHAW LM, OHANIAN J, HEAGERTY AM: Calcium sensitivity and agonist-induced calcium sensitization in small arteries of young and adult spontaneously hypertensive rats. Hypertension 30:442-448, 1997
108. 108. KRISTAL-BONEH E, FROOM P, HARAKI G, RIBAK J: Association of calcitriol and blood pressure in normotensive men. Hypertension 30:1289-1294, 1997
109. 109. KRAUSE R, BÜHRING M, HOPFENMÜLLER W, HOLICK MF, SHARMA AM: Ultraviolet B and blood pressure. Lancet 352:709-710, 1998
110. 110. THIERRY-PAMMER M, CARLYLE KS, WILLIAMS MD, TEWOLDE T, CAINES-MCKENZIE S, BAYWORTH MA, EMMETT NL, HARRISHOOKER SA, SANFORD GL, WILLIAMS EF: Plasma 25-hydroxyvitamin D concentrations are inversely associated with blood pressure of Dahl salt-sensitive rats. J Steroid Biochem Mol Biol 66:255-261, 1998
111. 111. KRAIKINPANITCH S, LINDEMAN RD, YOENICE AA, BAXTER DJ, HAYGOOD CC, BLUE MM: Effect of azotemia and myocardial accumulation of calcium. Miner Electrolyte Metab 1:12-20, 1978
112. 112. SOLOMON C, ROBERTS JE, LISA JR: The heart in uremia. Am J Pathol 18:729-732, 1942
113. 113. TERMAN DS, ALFREY AC, HAMMOND WS, DONNDELINGER T, OGDEN DA, HOLMES JH: Cardiac calcification in uremia: A clinical, biochemical and pathological study. Am J Med 50:744-755, 1971
114. 114. IBELS LS, ALFREY AC, HUFFER WE, CRASWELL PW, ANDERSON JT, WEIL R III: Arterial calcification and pathology in uremic patients undergoing dialysis. Am J Med 66:790-796, 1979
115. 115. MAZZAFERRO S, COEN G, BANDINI S, BORGATTI PP, CIACCHERI M, DIACINTI D, FERRANTI E, LUSENTI T, MANCINI G, MONDUCCI I, PASQUALI M, PELLEGRINI F, PERRUZZA I, TAGGI F, CINOTTI GA: Role of ageing, chronic renal failure and dialysis in the calcification of mithral annulus. Nephrol Dial Transplant 8:335-340, 1993
116. 116. EJERBLAD S, ERIKSSON I, JOHANSSON H: Uraemic arterial disease: An experimental study with special reference to the effect of parathyroidectomy. Scand Urol Nephrol 13:161-169, 1979
117. 117. EJERBLAD S, ERICSSON JLE, ERIKSSON I: Arterial lesions of the radial artery in uraemic patients. Acta Chir Scand 145:415-428, 1979
118. 118. BRAUN J, OLDENDORF M, MOSHAGE W, HEIDLER R, ZEITLER E, LUFT FC: Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 27:394-401, 1996
119. 119. KURZ P, MONIER-FAUGERE M-C, BOGNAR B, WERNER E, ROTH P, VLACHOJANNIS J, MALLUCHE HH: Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int 46:855-861, 1994
120. 120. MILLINER DS, ZINSMEISTER AR, LIEBERMAN E, LANDING B: Soft tissue calcification in pediatric patients with end-stage renal disease. Kidney Int 38:931-936, 1990
121. 121. HSU CH: Are we mismanaging calcium and phosphate metabolism in renal failure? Am J Kidney Dis 29:641-649, 1997
122. 122. WATSON KE, ABROLAT ML, MALONE LL, HOEG JM, DOHERTY T, DETRANO R, DEMER LL: Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96: 1755-1760, 1997
123. 123. HARRIS DCH, HAMMOND WS, BURKE TJ, SCHRIER RW: Verapamil protects against progression of experimental chronic renal failure. Kidney Int 31:41-46, 1987
124. 124. BLOCK GA, HULBERT-SHEARON TE, LEVIN NW, PORT FK: Association of serum phosphorus and calcium × phosphorus product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis 31:607-617, 1998